More adverse events leading to drug dose adjustment/interruption in the presence of MMF- vs everolimus-based inummosuppression in De Novo heart transplant patients

Vermes, E., Almenar, L., Vigano, M., MacCherini, M., Poncelet, A., Mattei, M.-F., Dengler, T., Delgado, J., Vanhaecke, J., Hexbam, M., & Mange, K. (2008). More adverse events leading to drug dose adjustment/interruption in the presence of MMF- vs everolimus-based inummosuppression in De Novo heart transplant patients. The Journal of Heart and Lung Transplantation, 27(2), S227-S228. https://doi.org/10.1016/j.healun.2007.11.478 (Original work published 2008)